Articles liés à Nanoparticles for Cancer Theraphy

Nanoparticles for Cancer Theraphy - Couverture souple

Vivek, Raju; Kannan, Soundarapandian; Nipunbabu, Varukattu

 
9783639707601: Nanoparticles for Cancer Theraphy

Synopsis

Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Nanoparticles (NPs) for cancer therapeutics are rapidly evolving and are being introduced in an attempt to overcome several limitations of conventional small-molecule chemotherapeutics. Though chemotherapy is successful to some extent in certain cancers, it has several limitations. Among the main drawbacks of chemotherapy are the lack of sufficient selectivity to the neoplasia and consequent toxicity to healthy tissues, limited bioaccessibility and bioavailability of drugs to the tumour tissues, hence that require a high dosage of drugs.

Biographie de l'auteur

R. Vivek had received his M. Sc and PhD degree from Bharathiar University. He did PhD programme in the following areas. His research focuses on advance nanotechnology research for cancer prevention, diagnosis, and treatment. In this context, His Ph.D work is pertaining to develop an innovative method to deliver drug of in "Nanomedicine"

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.